These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 839004)

  • 1. Synthesis of specific deuterium labeled tyrosine and phenylalanine derivatives and their use in the total synthesis of [8-arginine]vasopressin derivatives: The separation of diastereomeric [8-arginine]vasopressin derivatives by partition chromatography1,2.
    Yamamoto DM; Upson DA; Linn DK; Hruby VJ
    J Am Chem Soc; 1977 Mar; 99(5):1564-70. PubMed ID: 839004
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of peptides by fragment condensation on a solid support. II. A scheme for preparation of 4,8-disubstituted vasopressins evaluated on 8-arginine-vasopressin.
    Larsson LE; Melin P; Ragnarsson U
    Int J Pept Protein Res; 1976; 8(1):39-44. PubMed ID: 1248925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid, efficient synthesis of oxytocin and 8-arginine-vasopressin. Comparison of benzyl, p-methoxybenzyl, and p-methylbenzyl as protecting groups for cysteine.
    Live DH; Agosta WC; Cowburn D
    J Org Chem; 1977 Oct; 42(22):3556-61. PubMed ID: 915577
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of deuterium-labeled phenylalanine and tyrosine in human plasma with high pressure liquid chromatography and mass spectrometry.
    Trefz FK; Byrd DJ; Blaskovics ME; Kochen W; Lutz P
    Clin Chim Acta; 1976 Dec; 73(3):431-8. PubMed ID: 1000861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses of halogen derivatives of L-tryptophan, L-tyrosine and L-phenylalanine labeled with hydrogen isotopes.
    Pająk M; Pałka K; Winnicka E; Kańska M
    J Labelled Comp Radiopharm; 2016 Jan; 59(1):4-8. PubMed ID: 26586485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular-dichroic spectra of vasopressin analogues and their cyclic fragments.
    Fric I; Kodícek M; Flegel M; Zaoral M
    Eur J Biochem; 1975 Aug; 56(2):493-502. PubMed ID: 240713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic and linear vasopressin V1 and V1/V2 antagonists containing arginine in the 4-position.
    Sawyer WH; Lammek B; Misicka A; Kruszynski M; Kolodzieczyk A; Manning M
    Experientia; 1991 Jan; 47(1):83-6. PubMed ID: 1999249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectively deuterated amino acid analogues. Synthesis, incorporation into proteins and NMR properties.
    Matthews HR; Matthews KS; Opella SJ
    Biochim Biophys Acta; 1977 Mar; 497(1):1-13. PubMed ID: 321035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tyrosinase preparations on oxytocin, vasopressin and bradykinin.
    BISSET GW
    Br J Pharmacol Chemother; 1962 Apr; 18(2):405-20. PubMed ID: 13869528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On phenylalanine-2-lysine-vasopressin].
    BERDE B; WEIDMANN H; CERLETTI A
    Helv Physiol Pharmacol Acta; 1961; 19():285-302. PubMed ID: 13867479
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with the synthetic vasopressin derivative 1-desamino-8-D-arginine vasopressin (DDAVP) in the therapy of diabetes insipidus].
    Schrader D; Frahm H; Freisenhausen HD; Lüdecke D; Krüger HP
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1909-12. PubMed ID: 1030134
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of lower body negative pressure upon arginine vasopressin release.
    Baylis PH; Stockley RA; Heath DA
    Clin Endocrinol (Oxf); 1978 Jul; 9(1):89-95. PubMed ID: 679506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action and structural requirements of vasopressin analog inhibition of transepithelial water flux in toad urinary bladder.
    Mann WA; Stassen F; Huffman W; Kinter LB
    J Pharmacol Exp Ther; 1986 Aug; 238(2):401-6. PubMed ID: 3090234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Radioimmunoassay of arginine-vasopressin in urine.
    Khokhar AM; Ramage CM; Slater JD
    J Endocrinol; 1975 Nov; 67(2):66P-67P. PubMed ID: 1206315
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma-arginine-vasopressin response to insulin-induced hypoglycaemia.
    Baylis PH; Heath DA
    Lancet; 1977 Aug; 2(8035):428-30. PubMed ID: 70644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Proline and 4-hydroxyproline analogs of arginine vasopressin: role of the proline substitution in the two beta-turns of vasopressin.
    Buku A; Yamin N; Gazis D
    Experientia; 1987 Dec; 43(11-12):1218-9. PubMed ID: 3691742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved method and its clinical application of a radioimmunoassay of arginine vasopressin in human serum.
    Wagner H; Maier V; Franz HE
    Horm Metab Res; 1977 May; 9(3):223-7. PubMed ID: 885476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine vasopressin in health and disease.
    Br Med J; 1978 Jul; 2(6132):232-3. PubMed ID: 678879
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular considerations in the interaction of arginine vasopressin with a specific antiserum.
    Burford G; Lutterodt A; Moore G; Lederis K
    Proc West Pharmacol Soc; 1977; 20():521-5. PubMed ID: 896861
    [No Abstract]   [Full Text] [Related]  

  • 20. Production of antisera to [8-arginine]-vasopressin in homozygous Brattleboro rats.
    Lutterodt AT; Burford GD; Lederis K
    J Endocrinol; 1976 Oct; 71(1):161-2. PubMed ID: 978112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.